GL1X · GenesisL1 explorer

Research workbench

HIV integrase core domain in complex with inhibitor 2-(5-(3- fluorophenyl)-2-(2-(thiophen-2-YL)ETHYNYL)-1- benzofuran-3-yl) ethanoic acid

Analyse HIV integrase core domain in complex with inhibitor 2-(5-(3… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6WC8
Type
protein
Length
138 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Integrase
EC
2.7.7.-
UniProt
F2WR52
Ligands
TQM, IOD, SO4
Pockets
1 · best druggability 0.39

Structure

x-ray diffraction · 1 distinct chain · 50% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AIntegrase (EC 2.7.7.-)protein13850% helix, 22% strandF2WR52

Ligands and binding sites

  • TQM · {5-(3-fluorophenyl)-2-[(thiophen-2-yl)ethynyl]-1-benzofuran-3-yl}acetic acid · ligand · chains A
  • IOD · Iodide ion · ion · 4 copies · chains A
  • SO4 · Sulfate ion · ion · 4 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1570.390.8115empty

Compared structures

  • 6WC8 · HIV Integrase core domain in complex with inhibitor… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.